NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
In brief, in English
The NIH SBIR Phase IIB Strategic Breakthrough Award bridges the funding gap between Phase II awards and commercialization by supporting later-stage research and development. It is available to small businesses with previously funded NIH SBIR or STTR projects.
Written by a model from the publisher's text. The official page is the authority. How data is produced
The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).
Änderungsverlauf
First seen 28 Sept 2026, last checked 22 Nov 2026. 1 recorded version.
- 28 Sept 2026 · 718f771af38e